查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1801264

2025 年至 2033 年乳房影像市場規模、佔有率、趨勢及預測（按技術、最終用戶和地區）

Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球乳房影像市場規模達48.6億美元。展望未來， IMARC Group預測，到2033年，該市場規模將達到93億美元，2025年至2033年的複合年成長率為7.10%。目前，北美佔據乳房影像市場主導地位，2024年其乳房影像市場佔有率將超過37.5%。乳房影像市場的發展受到乳癌盛行率上升、影像技術進步以及政府提倡早期發現的舉措的推動。公眾意識的提升、醫療基礎設施的擴展以及人工智慧(AI)驅動的診斷技術進一步推動了市場成長。優惠的報銷政策以及對精準、非侵入性篩檢解決方案日益成長的需求也促進了行業擴張。

乳癌發生率的上升是乳房影像產業發展的主要驅動力，因此需要早期發現和先進的診斷解決方案。 2022年，全球約有230萬名女性被診斷出罹患乳癌，導致約67萬人死亡。然而，預測顯示，到2050年，病例數將增加38%，死亡人數將增加68%。在美國，乳癌診斷率每年成長1%，50歲以下女性的診斷率每年成長1.4%。這一令人擔憂的趨勢促使政府加強宣傳活動和計劃，提倡頻繁篩檢，推動了乳房X光檢查、超音波檢查和核磁共振成像技術的普及。3D(3D)乳房X光檢查和人工智慧影像等技術進步提高了篩檢準確性，減少了假陽性和不必要的活體組織切片。醫療保健基礎設施的不斷擴展，尤其是在新興市場，改善了篩檢中心的可近性，確保了更好的患者治療效果，並推動了影像技術的持續創新。

美國乳房影像市場受高乳癌盛行率、先進的醫療基礎設施以及政府大力推廣早期篩檢措施的驅動，市場佔有率高達88.90%。數位乳房斷層合成 (DBT) 和人工智慧診斷等先進影像技術的廣泛應用，提高了篩檢的準確性和效率。優惠的報銷政策以及美國癌症協會等組織所進行的宣傳活動，進一步鼓勵人們定期進行乳房X光檢查。此外，主要產業參與者持續的研發投入也促進了技術進步，提高了成像精度。主要市場參與者的加入，加上醫療創新投資的不斷增加，進一步增強了乳房影像市場的成長。保險覆蓋範圍的擴大和個性化診斷需求的不斷成長，進一步推動了乳房影像解決方案在全美範圍內的普及。

乳房影像市場趨勢：

乳癌發生率上升

乳房影像市場的主要趨勢之一是乳癌病例數量的增加，這是推動乳房影像產業成長的主要因素之一。早期發現可提高生存率，從而改善治療效果，因此對先進影像的需求激增。根據世界衛生組織的數據，乳癌是女性最常見的癌症，因此必須及時準確檢測乳癌。根據世界癌症研究基金會的數據，預計2030年將新增約210萬例乳癌病例，這進一步證明了對有效篩檢和影像解決方案的需求。乳癌病例的增加推動了先進影像技術的引入，同時也促使醫療系統和醫療服務提供者採用更好的安全診斷方案。早期發現對於改善治療效果至關重要，而乳房影像服務的需求也在成長，以適應這些不斷成長的需求變數和乳房影像市場。

成像技術的進步

乳房影像技術的持續進步顯著提升了乳房疾病的檢測和管理水平，預計將成為市場成長的關鍵驅動力。值得注意的是，數位乳房X光檢查、3D斷層合成、增強乳房X光檢查以及人工智慧驅動的成像解決方案的進步，都有助於提高診斷的精準度和效率，從而推動其應用。此類創新使醫療保健提供者能夠更早、更準確地診斷乳癌，從而改善患者的預後。近期一個很好的例子是通用電氣醫療集團 (GE HealthCare) 於2023年11月推出的MyBreastAI套件；它結合了三款由iCAD引入的人工智慧驅動的應用程式：用於2D乳房X光檢查的SecondLook、用於3D乳房X光檢查的ProFound AI以及PowerLook密度評估。該套件利用人工智慧技術簡化乳房成像流程，以便更快地進行診斷，從而改善此類成像的可及性。這些技術都滿足了市場對更優質、更精準的癌症檢測設備日益成長的需求，並將進一步促進乳房影像市場的需求。

政府和醫療機構提高乳癌認知度的舉措

日益增多的宣傳活動和政府舉措使得越來越多的乳房影像服務得以應用，因為早期檢測對於生存至關重要。世界各國政府和組織正在推出乳癌篩檢項目，擴大影像服務的可近性，特別是針對服務匱乏的人。這些舉措反過來又將診斷技術擴展到了先前尚未普及的領域，進一步刺激了市場成長。例如，每兩年，由政府資助的澳洲國家篩檢計畫「澳洲乳房篩檢」（BreastScreen Australia）都會為50-74歲的女性提供免費的乳房X光檢查，以鼓勵篩檢和早期檢測。此外，澳洲癌症協會於2020年9月發布的《早期乳癌管理指南—建議與實務要點》強調了早期診斷的重要性，從而推動了先進乳房影像技術的發展。這些舉措，加上公眾意識的不斷提升，在增加對高品質影像解決方案的需求以及全球乳房影像市場擴張方面發揮重要作用。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球乳房影像市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • 電離乳房成像
    • 主要類型
      • 乳房X光檢查
      • 正子斷層掃描-電腦斷層掃描
      • 分子乳房影像
      • 正電子發射乳房X光檢查
      • 錐形束電腦斷層掃描
  • 非電離乳房成像
    • 主要類型
      • 乳腺超音波檢查
      • 乳房MRI
      • 自動全乳超音波檢查
      • 乳房熱成像
      • 電阻抗斷層掃描
      • 光學成像

第7章：市場區隔：依最終用戶

  • 醫院
  • 診斷影像中心
  • 門診手術中心
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格指標

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allengers Medical Systems Limited
    • Aurora Health Care Inc. (Schoen Clinic)
    • Canon Inc.
    • Carestream Health Inc. (Onex Corporation)
    • Delphinus Medical Technologies
    • Dilon Technologies Inc.
    • Fujifilm Holdings Corporation
    • GE Healthcare
    • Hologic Inc.
    • Koninklijke Philips NV
    • Micrima Limited
    • Planmed Oy
    • Siemens Healthineers AG (Cerner Corporation)
    • Toshiba Corporation
Product Code: SR112025A2147

The global breast imaging market size was valued at USD 4.86 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.30 Billion by 2033, exhibiting a CAGR of 7.10% from 2025-2033. North America currently dominates the market, holding a breast imaging market share of over 37.5% in 2024. The breast imaging market is driven by rising breast cancer prevalence, technological advancements in imaging modalities, and government initiatives promoting early detection. Increased awareness, expanding healthcare infrastructure, and artificial intelligence (AI)-driven diagnostics further boost market growth. Favorable reimbursement policies and growing demand for accurate, non-invasive screening solutions also contribute to industry expansion.

The rising incidence of breast cancer is a major driver in the breast imaging industry, necessitating early detection and advanced diagnostic solutions. In 2022, approximately 2.3 million women globally were diagnosed with breast cancer, resulting in about 670,000 deaths. However, the projections indicate a 38% increase in cases and a 68% rise in deaths by 2050. In the U.S., diagnoses have been growing by 1% annually, with a 1.4% increase per year among women under 50. This alarming trend has intensified awareness campaigns and government initiatives promoting frequent screenings, driving the adoption of mammography, ultrasound, and MRI technologies. Technological advancements like three-dimensional (3D) mammography and AI-powered imaging enhance accuracy, reducing false positives and unnecessary biopsies. Expanding healthcare infrastructure, particularly in emerging markets, improves access to screening centers, ensuring better patient outcomes and continuous innovation in imaging technology.

The U.S. breast imaging market is driven by high breast cancer prevalence, advanced healthcare infrastructure, and strong government initiatives promoting early detection with 88.90% market share. Widespread adoption of advanced imaging technologies, such as digital breast tomosynthesis (DBT) and AI-driven diagnostics, enhances accuracy and efficiency in screenings. Favorable reimbursement policies and increased awareness campaigns by organizations like the American Cancer Society further encourage regular mammograms. Additionally, ongoing research and development (R&D) efforts by key industry players contribute to technological advancements, improving imaging precision. The presence of major market players, coupled with rising investments in healthcare innovations, strengthening the breast imaging market growth. Expanding insurance coverage and growing demand for personalized diagnostics further support the increasing adoption of breast imaging solutions across the country.

Breast Imaging Market Trends:

Increasing Incidence of Breast Cancer

On of the primary breast imaging market trends is the increasing number of breast cancer cases is one of the leading factors driving the growth of the breast imaging sector. Early detection improves survival and hence the treatment, thus surging demand for advanced imaging. It is the most commonly diagnosed cancer among women, as per WHO, necessitating accurate and timely detection of breast cancer. According to the World Cancer Research Fund, it is anticipated that there will be around 2.1 million new breast cancer cases in 2030, strengthening the argument for effective screening and imaging solutions. The rise of breast cancer cases drives the introduction of advanced imaging technologies while pushing the health system and providers to adopt better options in secure diagnosis. The measure of early detection is instrumental in improving treatment outcomes, and the demand for breast imaging services rises to accommodate these increased demand variables and the market for breast imaging.

Technological Advancements in Imaging Techniques

Continuous advancement in breast imaging technology significantly influences enhancement in detection and management of breast illnesses and conditions and is projected as a key driver for market growth. Notably, advancement in digital mammography, 3D tomosynthesis, contrast-enhanced mammography, and AI-driven imaging solutions, all contribute to increased diagnostic precision and efficiency, which in turn drives adoption. Innovations such as these allow healthcare providers to make earlier and more precise diagnoses of breast cancer, leading to improved outcomes for patients. An excellent recent example is the MyBreastAI suite launched by GE HealthCare in November 2023; it combines three iCAD-introduced AI-driven applications: SecondLook for 2D mammography, ProFound AI for 3D mammography, and PowerLook Density Assessment. This suite uses AI technology to streamline breast imaging for quicker diagnosis, thereby improving access to this kind of imaging. These technologies are all answers to the growing demand for better and more accurate devices for cancer detection that will further facilitate the breast imaging market demand.

Government and Healthcare Initiatives for Breast Cancer Awareness

The increasing awareness campaigns and government initiatives are allowing more and more breast imaging services to be utilized as early detection is very crucial to survival. Governments and organizations around the world are introducing breast cancer screening programs, expanding access to imaging services, especially for underserved populations. These, in turn, have expanded diagnostics into areas where they had previously not been available, further spurring market growth. For instance, every two years, the government-sponsored national screening program of Australia, BreastScreen Australia, offers women ages 50-74 free mammograms to encourage screening and early detection. Moreover, Cancer Australia's September 2020 publication, "Guidance for the Management of Early Breast Cancer-Recommendations and Practice Points," emphasized the significance of early diagnosis, stimulating the development of advanced breast imaging technologies. These instances, accompanied by a growing awareness among the public, are playing an important role in increasing the demand for high-quality imaging solutions and expanding the breast imaging market globally.

Breast Imaging Industry Segmentation:

Analysis by Technology:

  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography
    • Molecular Breast Imaging
    • Positron Emission Mammography
    • Cone-Beam Computed Tomography
  • Non-Ionizing Breast Imaging
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-Breast Ultrasound
    • Breast Thermography
    • Electric Impedance Tomography
    • Optical Imaging

According to the breast imaging market forecast, Ionizing breast imaging holds the majority share of 63.7% due to its widespread use in early breast cancer detection and diagnosis. Techniques such as mammography, digital breast tomosynthesis (DBT), and contrast-enhanced mammography provide high-resolution images, enabling accurate identification of abnormalities. The effectiveness of these methods in detecting microcalcifications and early-stage tumors makes them the preferred choice among healthcare providers. Additionally, government screening programs, rising breast cancer awareness, and increased adoption of advanced imaging technologies contribute to its dominance. The integration of artificial intelligence in mammography for improved diagnostic accuracy and workflow efficiency further strengthens market growth. Despite concerns over radiation exposure, continuous technological advancements in low-dose imaging ensure its continued preference in breast cancer diagnostics.

Analysis by End-User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Based on the breast imaging market outlook, Hospitals hold the largest market share of 42.0% due to their comprehensive veterinary care services, advanced diagnostic capabilities, and specialized treatment options. These facilities offer a wide range of medical interventions, including surgeries, critical care, and disease management, making them the preferred choice for pet owners and livestock farmers. The presence of skilled veterinary professionals, access to high-end medical equipment, and increasing investments in hospital infrastructure contribute to their dominance. Additionally, rising pet adoption rates and growing awareness of preventive healthcare are driving demand for hospital-based veterinary services. Government initiatives and corporate investments in multi-specialty veterinary hospitals further strengthen their market position, ensuring better accessibility and higher standards of animal healthcare across urban and rural areas.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America holds the leading market position with a 37.5% breast imaging market share, fueled by a robust healthcare infrastructure, widespread adoption of advanced medical technologies, and rising healthcare expenditures. The region benefits from strong government initiatives supporting disease screening, early diagnosis, and treatment advancements. A growing prevalence of chronic diseases, coupled with a rising aging population, fuels demand for cutting-edge medical imaging and diagnostic solutions. Additionally, robust research and development activities, along with a high concentration of key industry players, contribute to market growth. Favorable reimbursement policies and widespread health insurance coverage further boost accessibility to medical imaging services. Increasing awareness programs and strong regulatory frameworks ensure continued investment in healthcare innovations, reinforcing North America's market dominance.

Key Regional Takeaways:

United States Breast Imaging Market Analysis

Growing demand for next-generation breast imaging technologies in the US stems from the large number of regulatory clearances, growing rates of breast cancer diagnoses, and revised screening guidelines. In January 2021, Seno Medical Instruments gained Premarket Approval from CDRH for its new diagnostic modality in imaging, which is centered on the malignant vs. benign differentiation of breast lesions. This approval supports the rising adoption of advanced imaging solutions for accurate diagnosis. Meanwhile, the guidance from the CDC, released in September 2020, and recommendations from major institutes for cancer research on yearly screenings for women, aged 40 to 49, run a further push for the demand for imaging services. The Breastcancer.org states that around 281,550 fresh cases of invasive in women were diagnosed in the U.S. of breast cancer, enhancing the demand for early detection technologies. A combination of these factors results in the expanding breast imaging market in the United States.

Europe Breast Imaging Market Analysis

The increase in aging populace in Europe is a key driving force behind the growth of the breast imaging market, as aging is a significant risk factor for breast cancer. As per a report by the European Union, by February 2025, over 21.3% of the total EU population which is approximately 448.8 million-was aged 65 years and older in 2023. The changing demographics are foreseen to result in an increased incidence of breast cancer, hence driving the demand for advanced breast imaging technologies. With focus across Europe on early detection and preventive care, investments in screening programs and diagnostic imaging solutions are continuing to rise. Governments and healthcare companies are expanding the access to mammography, ultrasound, and MRI-based breast imaging services to respond to the rising need for timely and accurate diagnoses. Thus, the rising population and growing healthcare initiatives were expected to drive the European breast imaging market in the coming years.

Asia Pacific Breast Imaging Market Analysis

The increasing number of breast cancer incidences recorded in the Asia Pacific region, coupled with improving healthcare infrastructure, act as the main growth driver for the breast imaging market. According to a report published by Breast Cancer Network Australia in September 2024, approximately 20,973 women and 221 men will be diagnosed with breast cancer in Australia alone. This rising number of cases highlights the requirement for advanced breast imaging technologies to enable early identification and efficient treatment.

Governments and healthcare organizations in the region are investing in newer screening technologies, including digital mammography, ultrasound, and MRI services. Supportive initiatives on breast cancer awareness and early screening programs provide good access to breast imaging services, especially in developing countries. With ongoing improvements in healthcare infrastructure and adoption of state-of-the-art imaging technologies, the demand for breast imaging solutions in the Asia Pacific region is projected to grow steadily in the future.

Latin America Breast Imaging Market Analysis

Breast cancer is the most prevalent form of cancer among women in Latin America and Caribbean countries, compelling a growing interest in the development of advanced breast imaging technologies. According to the American Society of Clinical Oncology (ASCO), more than 200,000 new cases of breast cancer were diagnosed in the region in 2020. As such increased incidence demands for greater awareness and provides an impelling reason for the development of breast imaging market.

Breast cancer screening programs are actively implemented across the Latin American region by the government and health agencies to promote the early detection of this disease. Investment in advanced imaging modalities, including digital mammography, ultrasound, and MRI, has opened the door to equitable access to high-quality diagnostics. Also, awareness campaigns and partnerships with global health institutions are slowly closing the programs that detect breast cancer among poor communities. As these health systems develop and screening access improves, demand for breast imaging solutions is expected to rise steadily across Latin America.

Middle East and Africa Breast Imaging Market Analysis

The trials of rising breast cancer incidence in the Middle East and North Africa (MENA) are among the major forces influencing breast imaging growth. In 2019, there were 835,576 breast cancer cases among females and 10,938 among males, as per the Institute for Health Metrics and Evaluation (IHME). Incidence and burden of breast cancer here drive home the point quite well about the need for deployment of advanced imaging technology and methods for early detection and improved outcomes.

Governments and healthcare institutions in the Middle East and Africa are investing in expanding access to breast cancer screening programs. Countries such as the UAE, Saudi Arabia, and South Africa are implementing nationwide initiatives promoting regular mammograms and early diagnosis. The increasing adoption of digital mammography, 3D tomosynthesis, and AI-powered imaging solutions increases accuracy and accessibility to diagnosis. Furthermore, rising healthcare awareness, improved medical infrastructure, and partnerships with international health organizations will calm beyond the horizon in the regional market.

Competitive Landscape:

The breast imaging market is highly competitive, driven by continuous technological advancements and innovation in diagnostic imaging solutions. Market players focus on research and development to enhance imaging accuracy, reduce false positives, and integrate artificial intelligence for improved diagnostics. The industry sees strong competition in product differentiation, with companies offering advanced modalities such as digital breast tomosynthesis, automated breast ultrasound, and molecular breast imaging. Strategic collaborations with healthcare providers and research institutions play a crucial role in market positioning. Regulatory approvals and compliance with stringent safety standards influence market dynamics. Additionally, increasing mergers and acquisitions help companies expand their portfolios and global reach, intensifying competition while driving the overall evolution of breast imaging technologies.

The report provides a comprehensive analysis of the competitive landscape in the breast imaging market with detailed profiles of all major companies, including:

  • Allengers Medical Systems Limited
  • Aurora Health Care Inc. (Schoen Clinic)
  • Canon Inc.
  • Carestream Health Inc. (Onex Corporation)
  • Delphinus Medical Technologies
  • Dilon Technologies Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Micrima Limited
  • Planmed Oy
  • Siemens Healthineers AG (Cerner Corporation)
  • Toshiba Corporation

Key Questions Answered in This Report

  • 1.How big is the breast imaging market?
  • 2.What is the future outlook of breast imaging market?
  • 3.What are the key factors driving the breast imaging market?
  • 4.Which region accounts for the largest breast imaging market share?
  • 5.Which are the leading companies in the global breast imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Imaging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Ionizing Breast Imaging
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mammography
      • 6.1.2.2 Positron Emission Tomography-Computed Tomography
      • 6.1.2.3 Molecular Breast Imaging
      • 6.1.2.4 Positron Emission Mammography
      • 6.1.2.5 Cone-Beam Computed Tomography
    • 6.1.3 Market Forecast
  • 6.2 Non-Ionizing Breast Imaging
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Breast Ultrasound
      • 6.2.2.2 Breast MRI
      • 6.2.2.3 Automated Whole-Breast Ultrasound
      • 6.2.2.4 Breast Thermography
      • 6.2.2.5 Electric Impedance Tomography
      • 6.2.2.6 Optical Imaging
    • 6.2.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Imaging Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Allengers Medical Systems Limited
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Aurora Health Care Inc. (Schoen Clinic)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Canon Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Carestream Health Inc. (Onex Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Delphinus Medical Technologies
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Dilon Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Fujifilm Holdings Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 GE Healthcare
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Hologic Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke Philips N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Micrima Limited
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Planmed Oy
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
    • 13.3.13 Siemens Healthineers AG (Cerner Corporation)
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Toshiba Corporation
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Breast Imaging Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Imaging Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Breast Imaging Market: Breakup by Technology (in %), 2024
  • Figure 4: Global: Breast Imaging Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Breast Imaging Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Breast Imaging Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Breast Imaging (Ionizing Breast Imaging) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Breast Imaging (Ionizing Breast Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Breast Imaging (Non-Ionizing Breast Imaging) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Breast Imaging (Non-Ionizing Breast Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Breast Imaging (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Breast Imaging (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Breast Imaging (Diagnostic Imaging Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Breast Imaging (Diagnostic Imaging Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Breast Imaging (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Breast Imaging (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Breast Imaging (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Breast Imaging (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: United States: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: United States: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Canada: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Canada: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Asia Pacific: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Asia Pacific: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: China: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: China: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Japan: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Japan: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: India: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: India: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: South Korea: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: South Korea: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Australia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Indonesia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Indonesia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Latin America: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Latin America: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Brazil: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Brazil: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Mexico: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Mexico: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Middle East and Africa: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Middle East and Africa: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Global: Breast Imaging Industry: SWOT Analysis
  • Figure 68: Global: Breast Imaging Industry: Value Chain Analysis
  • Figure 69: Global: Breast Imaging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Imaging Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Breast Imaging Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Breast Imaging Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Breast Imaging Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Breast Imaging Market: Competitive Structure
  • Table 6: Global: Breast Imaging Market: Key Players